Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Proton and Heavy Ion Center (SPHIC) is a premier medical facility in China specializing in advanced radiotherapy for cancer treatment. It is the first center in China, and one of the few globally, to offer both proton and carbon-ion beam therapies, which allow for highly precise targeting of tumors while minimizing damage to surrounding healthy tissue. The center operates as a clinical, research, and training hub, focusing on complex cases such as head and neck, thoracic, and abdominal malignancies. SPHIC is affiliated with the Fudan University Shanghai Cancer Center and represents a significant investment in high-end medical technology within the Yangtze River Delta region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Proton.